Position in RPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,963,824
+$1,812,029 QoQ
Shares Held
213,373
+0.8% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#138
of 635 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $511,704,326 across 163 Biotechnology names. RPRX ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,798 | $67,454,940 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
55,287 | $34,473,655 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
70,171 | $21,123,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
83,892 | $15,711,293 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
248,821 | $15,018,835 | |
| 6 | MRNA |
Moderna, Inc.
|
207,705 | $14,545,581 | |
| 7 | INSM |
INSMED Inc
|
118,057 | $12,587,237 | |
| 8 | RPRX |
Royalty Pharma plc
This page
|
213,373 | $11,963,824 |
All Filings in RPRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,963,824 | 213,373 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,151,795 | 211,628 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,996,586 | 206,951 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,390,877 | 209,492 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,196,848 | 199,746 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,457,160 | 239,549 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,357,074 | 209,999 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,137,939 | 216,965 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,306,355 | 201,227 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,146,159 | 202,376 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,531,988 | 196,938 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $5,501,467 | 202,707 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,030,050 | 196,163 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,739,879 | 187,063 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,366,225 | 211,696 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,361,337 | 232,985 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,679,048 | 277,808 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,714,013 | 249,333 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,941,351 | 174,187 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,046,415 | 111,965 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,288,537 | 104,624 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,712,792 | 108,042 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,696,193 | 53,870 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $480,439 | 11,420 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||